Pushing Cell and Gene Therapy over the brink with better enzymes
#35 of 55 therapeutics startups
▲ 1 since the last ranking
Ranked 6:02 AM PT · Thu, Nov 19
Listed
Brink Therapeutics develops programmable recombinases — a precise, nuclease-free alternative to CRISPR for the next generation of cell and gene therapies.
If a fact is wrong, or you want the profile removed, tell us: we act on every request within 2 business days.